Clinical Trials on PROSTATE CANCER in Poland
Total 3192 results
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Providence Health & ServicesMedImmune LLCCompletedProstate Cancer | Metastatic Prostate Cancer | Cancer of the ProstateUnited States
-
Jeanne LinkOregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...Approved for marketingProstatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Portland VA Medical CenterNational Cancer Institute (NCI); OHSU Knight Cancer Institute; Oregon State UniversityCompletedProstate Cancer PreventionUnited States
-
Maria Sklodowska-Curie National Research Institute...Unknown
-
BioProtectCompletedProstate CancerPoland, Portugal
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
OHSU Knight Cancer InstituteOregon Health and Science University; Progenics Pharmaceuticals, Inc.Not yet recruitingProstate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate CancerUnited States
-
Genzyme, a Sanofi CompanyCompletedHormone-refractory Prostate CancerUnited States
-
Julie Graff, MDJohns Hopkins University; Merck Sharp & Dohme LLC; Oregon Health and Science... and other collaboratorsRecruitingProstate Cancer | Prostate Cancer MetastaticUnited States
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationTerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Hormone-Resistant Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
The Greater Poland Cancer CentreRecruiting
-
National Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Bone | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
OHSU Knight Cancer InstituteThe Wayne D. Kuni and Joan E. Kuni FoundationCompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Portland VA Medical CenterCompletedProstate Cancer | Hereditary Prostate CancerUnited States
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
The Greater Poland Cancer CentreRecruiting
-
Radboud University Medical CenterNot yet recruitingProstate Cancer | Prostate NeoplasmNetherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
The Greater Poland Cancer CentreCompletedProstate CancerPoland
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Jagiellonian UniversityUniversity Hospital in KrakowRecruitingProstatic Neoplasms | Prostatic Hyperplasia | Prostate Cancer | Neuroendocrine Tumors | Neuroendocrine Carcinoma | Prostate Cancer MetastaticPoland
-
University of Erlangen-Nürnberg Medical SchoolUnknown
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Eli Lilly and CompanyCompletedAdenocarcinoma of the ProstateUnited States
-
Erasmus Medical CenterRecruitingProstate Cancer MetastaticNetherlands
-
BioProtectRecruitingProstate CancerIreland, Israel, Netherlands, Poland, Portugal
-
UNC Lineberger Comprehensive Cancer CenterJohns Hopkins University; Memorial Sloan Kettering Cancer Center; United States... and other collaboratorsCompletedMetastatic Castrate-Resistant Prostate CancerUnited States
-
VA Office of Research and DevelopmentOregon Health and Science UniversityCompleted
-
Grupo de Investigación Clínica en Oncología RadioterapiaCompletedOligometastatic Prostate CancerSpain
-
Medical University of BialystokMedical Research Agency, PolandRecruiting
-
Oregon Health and Science UniversityWithdrawn
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Cell GenesysUnknown
-
OHSU Knight Cancer InstituteActive, not recruitingProstate CancerUnited States
-
The Netherlands Cancer InstituteUnknownProstate CancerNetherlands
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Oregon Health and Science UniversityCompletedProstate CancerUnited States
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningProstate CancerUnited States
-
University Urological Associates Inc.Unknown
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico